Enzyme‐based therapy has garnered significant attention for its current applications in
various diseases. Despite the notable advantages associated with the use of enzymes as …

Management of myocardial infarction complicated by cardiogenic shock: Expert opinion of the
Association of Intensive Cardiac C Page 1 www.journals.viamedica.pl/kardiologia_polska 1312 …

Background Fibrin-rich clot formation in thrombo-occlusive pathologies is currently treated
by systemic administration of plasminogen activators (eg tPA), to convert fibrin-associated …

Background To reestablish blood flow in vessels occluded by clots, tissue plasminogen
activator (tPA) can be used; however, its efficacy is limited by transport to and into a clot and …

Myocardial infarction (MI) is a serious cardiovascular disease with high morbidity and
mortality rates, posing a significant threat to patient's health and quality of life. Following a …

Nonsteroidal anti-inflammatory drugs (NSAIDs) are over-the-counter drugs and one of the
most widely used pharmacological groups worldwide, their chronic use is limited due to their …

El infarto de miocardio con elevación del segmento ST (IMCEST) es una entidad clínica
cuyo tratamiento adecuado dependerá de su pronto reconocimiento, diagnóstico certero y …

目的: 探索常德农村地区急性ST 段抬高型心肌梗死(ST-segmentelevationmyocardialinfarction,
STEMI) 患者院前溶栓治疗后的临床结局和生存趋势. 方法: 观察2020-2022 …

OBJECTIVE: This study aimed to investigate the effects of ticagrelor on myocardial
microcirculation, cardiac function, and adverse cardiovascular events in ST-segment …

OBJECTIVE: The aim of the study was to investigate the clinical value of the Global Registry
of Arterial Events in Acute Coronary Syndromes (GRACE) score combined with the D …